Loading...

The first new treatment in 40 years

Nereus is the first FDA-approved treatment for motion vomiting in more than 40 years.

↓
60%
motionvomiting
See the data

In clinical studies, Nereus decreased the vomiting rate by 60%.

See Important Safety Information below.

Prescription required. No insurance needed.

Select Your Quantity

$255insurance list price
$85cash pay per capsule

Minimum quantity 2 capsules · Prescription required

From order to your door in 3 steps

1

Order Now

Select quantity and complete secure cash payment

2

Send Prescription

Have your provider send the eRx to the pharmacy

3

Free 2-day shipping to your door

Enjoy free 2-day shipping, fulfilled by the pharmacy

Questions?

Email CustomerService@nereus.us ›

About NEREUS™

NEREUS (tradipitant) 85 mg capsules

NEREUS™ (tradipitant) is a prescription NK1 receptor antagonist developed for the prevention of vomiting induced by motion.

IndicationPrevention of vomiting due to motion.
Strength85 mg tradipitant per capsule.
Key Benefits
  • ✔ Decreased vomiting rate by 60% in studies
  • ✔ Once a day dosing
  • ✔ Suitable for travel by sea, air, or land
Important: Prescription required. You will receive instructions once you place your order.

Indication and Important Safety Information for NEREUS™ (tradipitant) capsules.

INDICATION

NEREUS™ (NEER-ee-us) [tradipitant] is a prescription medication used for the prevention of vomiting induced by motion in adults.

IMPORTANT SAFETY INFORMATION

NEREUS™ may impair abilities required for driving a motor vehicle or operating heavy machinery. Combining NEREUS™ with sedatives or medications that increase NEREUS™ levels may increase this effect. If use together cannot be avoided, your doctor may warn against driving or operating heavy machinery.

The most common side effects associated with NEREUS™ include drowsiness, headache, and fatigue.

Tell your healthcare provider about all of the medicines you’re taking. Strong CYP3A4 inhibitors may increase NEREUS™ levels and the risk of side effects.

Tell your healthcare provider about all of your health conditions, including if you have liver or kidney problems, or if you are pregnant, planning to become pregnant, or breastfeeding. There are limited data on NEREUS™ use in pregnant women.

Monitor breastfed infants for drowsiness.

The safety and effectiveness of NEREUS™ for the prevention of vomiting induced by motion in children have not been established.

NEREUS™ is not recommended in patients with liver problems or severe kidney problems.

Consumer Important Safety Information

You are encouraged to report side effects of prescription drugs to the FDA. To report side effects, contact Vanda Pharmaceuticals Inc. at 1-844-GO-VANDA (1-844-468-2632) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

For more information, ask your healthcare provider or call 1-844-468-2632.

This information does not take the place of talking with your healthcare provider for medical advice about your condition or treatment.

Download the full US Prescribing Information for details.